113 related articles for article (PubMed ID: 11394932)
1. Current perspectives on the development of non-biogenic amine-based antidepressants.
Skolnick P; Legutko B; Li X; Bymaster FP
Pharmacol Res; 2001 May; 43(5):411-23. PubMed ID: 11394932
[TBL] [Abstract][Full Text] [Related]
2. Modulation of glutamate receptors: strategies for the development of novel antidepressants.
Skolnick P
Amino Acids; 2002; 23(1-3):153-9. PubMed ID: 12373530
[TBL] [Abstract][Full Text] [Related]
3. Beyond monoamine-based therapies: clues to new approaches.
Skolnick P
J Clin Psychiatry; 2002; 63 Suppl 2():19-23. PubMed ID: 15453010
[TBL] [Abstract][Full Text] [Related]
4. Glutamate-based antidepressants: 20 years on.
Skolnick P; Popik P; Trullas R
Trends Pharmacol Sci; 2009 Nov; 30(11):563-9. PubMed ID: 19837463
[TBL] [Abstract][Full Text] [Related]
5. [Mechanism of action of antidepressants and therapeutic perspectives].
Bourin M; David DJ; Jolliet P; Gardier A
Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050.
Shaw AM; Boules M; Zhang Y; Williams K; Robinson J; Carlier PR; Richelson E
Eur J Pharmacol; 2007 Jan; 555(1):30-6. PubMed ID: 17109850
[TBL] [Abstract][Full Text] [Related]
7. Monoamine neurocircuitry in depression and strategies for new treatments.
Hamon M; Blier P
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
[TBL] [Abstract][Full Text] [Related]
8. The mGluR7 allosteric agonist AMN082 produces antidepressant-like effects by modulating glutamatergic signaling.
Bradley SR; Uslaner JM; Flick RB; Lee A; Groover KM; Hutson PH
Pharmacol Biochem Behav; 2012 Mar; 101(1):35-40. PubMed ID: 22138407
[TBL] [Abstract][Full Text] [Related]
9. Antidepressants for the new millennium.
Skolnick P
Eur J Pharmacol; 1999 Jun; 375(1-3):31-40. PubMed ID: 10443562
[TBL] [Abstract][Full Text] [Related]
10. Drug Development in Psychiatry: The Long and Winding Road from Chance Discovery to Rational Development.
Preskorn SH
Handb Exp Pharmacol; 2019; 250():307-324. PubMed ID: 30570691
[TBL] [Abstract][Full Text] [Related]
11. [Action mechanism of antidepressive drugs. Review of current knowledge].
Panichi C; Faravelli C
Riv Patol Nerv Ment; 1984; 105(6):249-82. PubMed ID: 6100975
[TBL] [Abstract][Full Text] [Related]
12. The role of glutamate on the action of antidepressants.
Hashimoto K
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1558-68. PubMed ID: 20600468
[TBL] [Abstract][Full Text] [Related]
13. Can monoamine-based therapies be improved?
Demitrack MA
J Clin Psychiatry; 2002; 63 Suppl 2():14-8. PubMed ID: 15453009
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice.
Dhir A; Malik S; Kessar SV; Singh KN; Kulkarni SK
Eur Neuropsychopharmacol; 2011 Sep; 21(9):705-14. PubMed ID: 21277753
[TBL] [Abstract][Full Text] [Related]
15. Does increasing the ratio of AMPA-to-NMDA receptor mediated neurotransmission engender antidepressant action? Studies in the mouse forced swim and tail suspension tests.
Andreasen JT; Gynther M; Rygaard A; Bøgelund T; Nielsen SD; Clausen RP; Mogensen J; Pickering DS
Neurosci Lett; 2013 Jun; 546():6-10. PubMed ID: 23643996
[TBL] [Abstract][Full Text] [Related]
16. Strategies for producing faster acting antidepressants.
Adell A; Castro E; Celada P; Bortolozzi A; Pazos A; Artigas F
Drug Discov Today; 2005 Apr; 10(8):578-85. PubMed ID: 15837601
[TBL] [Abstract][Full Text] [Related]
17. On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressants.
Pałucha A; Pilc A
Pol J Pharmacol; 2002; 54(6):581-6. PubMed ID: 12866712
[TBL] [Abstract][Full Text] [Related]
18. Biological basis of depression and therapeutic relevance.
Richelson E
J Clin Psychiatry; 1991 Jun; 52 Suppl():4-10. PubMed ID: 1646793
[TBL] [Abstract][Full Text] [Related]
19. Designing new treatments for depression and anxiety.
Chen Z; Yang J; Tobak A
IDrugs; 2008 Mar; 11(3):189-97. PubMed ID: 18311656
[TBL] [Abstract][Full Text] [Related]
20. On the use of selective neurotoxic amine analogs to measure the blockade of norepinephrine and 5-hydroxytryptamine uptake systems by antidepressants.
VonVoigtlander PF; Losey EG
Res Commun Chem Pathol Pharmacol; 1976 Mar; 13(3):389-400. PubMed ID: 132686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
